| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $726.4M | +40.4% |
| Cost of Revenue | $41.6M | +309.6% |
| Gross Profit | $684.8M | +35.1% |
| R&D Expense | $351.6M | -2.8% |
| SG&A Expense | $406.6M | +10.2% |
| Operating Income | -$73.4M | +67.2% |
| Pre-tax Income | -$51.0M | +76.1% |
| Income Tax | $10.3M | +305.0% |
| Net Income | -$61.3M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $188.7M | +64.3% |
| Accounts Receivable | $98.3M | +58.0% |
| Inventory | $40.4M | +249.9% |
| Current Assets | $616.1M | +21.3% |
| Total Assets | $749.0M | +27.4% |
| Current Liabilities | $254.3M | +102.4% |
| Total Liabilities | $317.2M | +69.3% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $16.7M | +114.6% |
| Capital Expenditures | $50K | — |
| Investing Cash Flow | $32.0M | -56.3% |
| Financing Cash Flow | $25.1M | +206.5% |
| Free Cash Flow | $16.7M | +114.6% |
| +71.6% |
| EPS (Basic) | -$0.37 | +72.4% |
| EPS (Diluted) | -$0.37 | +72.4% |
| Stockholders' Equity |
| $431.8M |
| +7.8% |